JNJ-47965567 |
Katalog-Nr.GC43931 |
JNJ-47965567 ist ein zentral durchlÄssiger, hochaffiner, selektiver P2X7-Antagonist mit pKis-Werten von 7,9 und 8,7 fÜr menschliches bzw. Ratten-P2X7.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1428327-31-4
Sample solution is provided at 25 µL, 10mM.
JNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel. Activation of P2X receptors by BzATP induces calcium flux, which is reduced by JNJ-47965567 in 1321N1 cells transfected with recombinant P2X7 human, macaque, dog, rat, or mouse protein with pIC50s of 8.3, 8.6, 8.5, 7.2, or 7.5, respectively. JNJ-47965567 suppresses neonatal hypoxia-induced seizures in mice and has some anticonvulsant properties in rats. It also reduces spontaneous seizures in epileptic mice even after treatment is stopped.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *